247 related articles for article (PubMed ID: 24282347)
1. Autoantibodies and an immune-based rat model of inflammatory bowel disease.
Esmaily H; Sanei Y; Abdollahi M
World J Gastroenterol; 2013 Nov; 19(43):7569-76. PubMed ID: 24282347
[TBL] [Abstract][Full Text] [Related]
2. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory bowel disease: autoimmune or immune-mediated pathogenesis?
Wen Z; Fiocchi C
Clin Dev Immunol; 2004; 11(3-4):195-204. PubMed ID: 15559364
[TBL] [Abstract][Full Text] [Related]
4. Interaction Between Commensal Bacteria, Immune Response and the Intestinal Barrier in Inflammatory Bowel Disease.
Chen Y; Cui W; Li X; Yang H
Front Immunol; 2021; 12():761981. PubMed ID: 34858414
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory bowel disease: pathogenesis.
Zhang YZ; Li YY
World J Gastroenterol; 2014 Jan; 20(1):91-9. PubMed ID: 24415861
[TBL] [Abstract][Full Text] [Related]
6. Prebiotics in inflammatory bowel diseases.
Guarner F
Br J Nutr; 2007 Oct; 98 Suppl 1():S85-9. PubMed ID: 17922967
[TBL] [Abstract][Full Text] [Related]
7. Innate Lymphoid Cells in Intestinal Homeostasis and Inflammatory Bowel Disease.
Saez A; Gomez-Bris R; Herrero-Fernandez B; Mingorance C; Rius C; Gonzalez-Granado JM
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299236
[TBL] [Abstract][Full Text] [Related]
8. Immunopathology of inflammatory bowel disease.
Wallace KL; Zheng LB; Kanazawa Y; Shih DQ
World J Gastroenterol; 2014 Jan; 20(1):6-21. PubMed ID: 24415853
[TBL] [Abstract][Full Text] [Related]
9. miRNAs as new molecular insights into inflammatory bowel disease: Crucial regulators in autoimmunity and inflammation.
Xu XM; Zhang HJ
World J Gastroenterol; 2016 Feb; 22(7):2206-18. PubMed ID: 26900285
[TBL] [Abstract][Full Text] [Related]
10. News from the "5th International Meeting on Inflammatory Bowel Diseases" CAPRI 2010.
Latella G; Fiocchi C; Caprili R
J Crohns Colitis; 2010 Dec; 4(6):690-702. PubMed ID: 21122584
[TBL] [Abstract][Full Text] [Related]
11. Enteric bacterial proteases in inflammatory bowel disease- pathophysiology and clinical implications.
Carroll IM; Maharshak N
World J Gastroenterol; 2013; 19(43):7531-43. PubMed ID: 24431894
[TBL] [Abstract][Full Text] [Related]
12. Cellular and Molecular Therapeutic Targets in Inflammatory Bowel Disease-Focusing on Intestinal Barrier Function.
Schoultz I; Keita ÅV
Cells; 2019 Feb; 8(2):. PubMed ID: 30813280
[TBL] [Abstract][Full Text] [Related]
13. Intestinal barrier dysfunction in inflammatory bowel diseases.
McGuckin MA; Eri R; Simms LA; Florin TH; Radford-Smith G
Inflamm Bowel Dis; 2009 Jan; 15(1):100-13. PubMed ID: 18623167
[TBL] [Abstract][Full Text] [Related]
14. [Inflammatory bowel disease: IBD].
Endo K; Shiga H; Kinouchi Y; Shimosegawa T
Rinsho Byori; 2009 Jun; 57(6):527-32. PubMed ID: 19621784
[TBL] [Abstract][Full Text] [Related]
15. Gut-lung crosstalk in pulmonary involvement with inflammatory bowel diseases.
Wang H; Liu JS; Peng SH; Deng XY; Zhu DM; Javidiparsijani S; Wang GR; Li DQ; Li LX; Wang YC; Luo JM
World J Gastroenterol; 2013 Oct; 19(40):6794-804. PubMed ID: 24187454
[TBL] [Abstract][Full Text] [Related]
16. Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease.
Raftery AL; Tsantikos E; Harris NL; Hibbs ML
Front Immunol; 2020; 11():2144. PubMed ID: 33042125
[TBL] [Abstract][Full Text] [Related]
17. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
18. Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance.
Caradonna L; Amati L; Magrone T; Pellegrino NM; Jirillo E; Caccavo D
J Endotoxin Res; 2000; 6(3):205-14. PubMed ID: 11052175
[TBL] [Abstract][Full Text] [Related]
19. Biologic therapy for inflammatory bowel disease.
Ardizzone S; Bianchi Porro G
Drugs; 2005; 65(16):2253-86. PubMed ID: 16266194
[TBL] [Abstract][Full Text] [Related]
20. Probiotics and inflammatory bowel diseases.
Bai AP; Ouyang Q
Postgrad Med J; 2006 Jun; 82(968):376-82. PubMed ID: 16754706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]